Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells.
about
Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.An Activin A/BMP2 chimera, AB215, blocks estrogen signaling via induction of ID proteins in breast cancer cells.Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patientsThe Yin and Yang of bone morphogenetic proteins in cancer.The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas.BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environmentSmall molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthThe bone morphogenetic protein receptor-1A pathway is required for lactogenic differentiation of mammary epithelial cells in vitroDeletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation.Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance.Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells.Viral vector-induced expression of bone morphogenetic protein 2 produces inhibition of tumor growth and bone differentiation of stem cells.Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents.Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation.BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1.BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERKAkt serine threonine kinase regulates platelet-derived growth factor-induced DNA synthesis in glomerular mesangial cells: regulation of c-fos AND p27(kip1) gene expression.BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels.Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.Phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells.BMP-2 inhibits lung metastasis of osteosarcoma: an early investigation using an orthotopic model
P2860
Q30442325-A05B7608-D7BC-4BC5-8574-4227B3858A27Q34006810-30A25A6B-0B57-47A3-8F37-F3CAAAD6C163Q34008631-48529D99-DEAD-43A6-BF68-9D27761DEE73Q34127207-2E5B835E-040B-41E2-918A-CD09655597A1Q34346737-5D4BA0C2-3D40-40E9-9522-DDC918A2BC8FQ34633696-76D81A00-D5FD-47A9-8FD0-92BFEE488419Q34992889-D6E877A8-2CC3-4775-ACEF-8094087AD38EQ36011433-28D1C077-11B9-4B26-A391-A02A3352850EQ36115488-27637BE3-9893-413E-906D-E495DE6932E8Q36356105-F5D227C1-68EA-448A-8A20-10917245D243Q36936190-C7662334-408A-4523-8C4C-CE90EC750324Q36940496-A3EA0965-B277-4633-9B08-5D52B2853724Q38115632-9498D19B-010A-44FD-A2F3-E6433CCC22F8Q38309344-5FD88842-3E76-4CAB-BAB0-87830106C41CQ38928611-F6852D3F-64EA-416F-BA6B-EFAC9DCF1960Q39020596-AC71CA31-A094-4185-B4EB-9B26B1DAFD2BQ39177327-B3028ADB-48D3-4AD8-A61B-F1DC0BD2BC34Q39406754-B6B40F58-17B8-45B0-A022-AC2E6D85CA05Q39451397-814EAEF2-F612-4578-A389-1BA4C44FB4C1Q39620793-9FFF7879-ECE9-484D-AE16-65E8C249A34EQ39786869-6C98AA13-2EBB-488D-A841-E54F538151F8Q40180664-6621DA5B-3AAE-4239-8686-F44E49B572D8Q40192599-68F01395-80FD-48B5-AF18-CD3DD32FFE5AQ40677649-371A117D-0E78-41CE-B271-F68948B10D5AQ42325847-35C3B919-9F12-49A7-B991-49D60FA0631EQ43686297-B98F51CA-A7AC-48FB-A755-53CF39250732Q44350476-07ED02CF-8EB5-44C4-9CB4-6BFA96A3DF1DQ47250561-2D6E0D2A-69C8-4A90-ADE9-ACDB8188DE37Q48006829-994EE79E-A8AD-4D72-8138-6C83F51721A2Q59135256-BEC89596-963C-489E-9EDC-CCFF9FE3A72F
P2860
Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Bone morphogenetic protein-2 i ...... F-7 human breast cancer cells.
@en
type
label
Bone morphogenetic protein-2 i ...... F-7 human breast cancer cells.
@en
prefLabel
Bone morphogenetic protein-2 i ...... F-7 human breast cancer cells.
@en
P2093
P1476
Bone morphogenetic protein-2 i ...... F-7 human breast cancer cells.
@en
P2093
G Ghosh-Choudhury
J Kreisberg
N Ghosh-Choudhury
S L Abboud
P304
P356
10.1016/S0167-4889(00)00060-4
P577
2000-07-01T00:00:00Z